Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence and risk factors for inhibitor development in previously untreated severe haemophilia A patients born between 2005 and 2010.
Vézina C, Carcao M, Infante-Rivard C, Lillicrap D, Stain AM, Paradis E, Teitel J, Rivard GE; Association of Hemophilia Clinic Directors of Canada and of the Canadian Association of Nurses in Hemophilia Care. Vézina C, et al. Haemophilia. 2014 Nov;20(6):771-6. doi: 10.1111/hae.12479. Epub 2014 Jul 17. Haemophilia. 2014. PMID: 25039669
Deciphering a novel complex inversion affecting F8 in a family with severe haemophilia A by optical genome mapping.
Fahiminiya S, Oikonomopoulos S, Rivard GE, Gandhi M, Scott P, Montpetit A, Chen SH, Park K, Vezina C, Ragoussis J, Carvalho CMB, Mitchell GA, Soucy JF, Gauthier J. Fahiminiya S, et al. Among authors: vezina c. Haemophilia. 2023 May;29(3):921-924. doi: 10.1111/hae.14771. Epub 2023 Mar 10. Haemophilia. 2023. PMID: 36897533 Free PMC article. No abstract available.
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.
Geoerger B, Kang HJ, Yalon-Oren M, Marshall LV, Vezina C, Pappo A, Laetsch TW, Petrilli AS, Ebinger M, Toporski J, Glade-Bender J, Nicholls W, Fox E, DuBois SG, Macy ME, Cohn SL, Pathiraja K, Diede SJ, Ebbinghaus S, Pinto N. Geoerger B, et al. Among authors: vezina c. Lancet Oncol. 2020 Jan;21(1):121-133. doi: 10.1016/S1470-2045(19)30671-0. Epub 2019 Dec 4. Lancet Oncol. 2020. PMID: 31812554 Clinical Trial.
223 results